SPRY4 and hepatocellular carcinoma: These results suggest that SPRY4-IT1 may serve as a novel target for the management of HCC or as a biomarker for HCC diagnosis or prognosis, though the detailed molecular mechanisms of SPRY4-IT1 on HCC development may require further investigation.